News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Luna DNA is the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community. SAN DIEGO, Dec. 18, 2017 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included... Read more
New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes Oncomine Myeloid Research Assay leverages Thermo Fisher’s next-generation sequencing to analyze 74 genes in a single panel and overcome hurdles of sequential-based clinical research CARLSBAD, Calif., Dec. 7, 2017 /PRNewswire/ — Clinical researchers interested in studying driver mutations suspected... Read more
CMS Issues Proposed National Coverage Determination of NGS IVDs Including Thermo Fisher Scientific’s Oncomine Dx Target Test The proposed national coverage determination provides Medicare beneficiaries with reimbursable testing using multi-biomarker NGS IVD tests to better inform treatment decisions CARLSBAD, Calif., Dec. 7, 2017 /PRNewswire/ — The Centers for Medicare & Medicaid Services (CMS) has proposed coverage... Read more
New Salmonella Multiplex PCR Solution offers First Validated Assay for Simultaneous Detection of Three Salmonella Targets in One Rapid Test Real-Time PCR workflow gains AOAC-RI approval for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England, Dec. 5, 2017 /PRNewswire/ — Poultry and pork producers can now rapidly screen for... Read more
ORLANDO, Fla., Dec. 4, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today revealed several technology innovations to further optimize the entire medication management process at this year’s American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting. In addition to the recent introduction of the BD HealthSight™ platform... Read more
London, UK, Nov 30, 2017 LGC and NuGEN have today announced a collaboration agreement for the commercialisation of the Single Primer Enrichment Technology (SPET) and distribution of Allegro Targeted Genotyping reagents for NGS library preparation. This collaboration will benefit customers of both LGC and NuGEN, as it expands options to access the SPET technology through the SeqSNP service in LGC’s global service... Read more
ST. LOUIS and VIENNA — 11/28/17 — Partek and Lexogen scientists have joined forces to deliver an easy-to-use analysis pipeline in Partek® Flow® software for data generated by Lexogen’s QuantSeq 3’ Library Prep Kits. QuantSeq is an economical protocol for RNA-Seq gene expression analysis and provides an alternative to microarrays. This pipeline enables Lexogen customers to import raw sequencing files directly into Partek... Read more
HERCULES, Calif — November 28, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced that its board of directors has authorized a new share repurchase program, granting the Company authority to repurchase, on a discretionary basis, up to $250 million of the outstanding... Read more
New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific’s portfolio of genome editing products CARLSBAD, Calif., Nov. 27, 2017 /PRNewswire/ — As researchers continue their quest to create more relevant cellular models, they now have access to a comprehensive portfolio of solutions from Thermo Fisher Scientific designed to maximize the performance of their genome... Read more
Thu 16th November 2017 Oxford Nanopore’s goal is to enable the analysis of any living thing, by anyone, anywhere. To get closer to this, we want to abolish the cold chain so that our reagents can be transported easily to any researcher and be used in any environment. With this in mind, we are now starting... Read more